Initial studies suggested that GATA3 is relatively sensitive and specific for tumors of breast or urothelial origin, and the downregulation of GATA3 has also been found to be associated with a poor prognosis of breast cancer. This evidence concerns the gene GATA3 and breast carcinoma.